HUMAN RECOMBINANT AMY2 (CALCITONIN+RAMP2) RECEPTOR

MULTISCREEN™ STABLE CELL LINE

Product Information

Catalog Number:
C1510-1a

Lot Number:
C1510-1-092817

Quantity:
1 vial (2 x 106) frozen cells

Freeze Medium:
Cell Banker 2 (Amsbio 11891)

Host cell:
CHO-K1

Transfection:
Full-length Human CT cDNA (GenBank Accession Number NM_001742) with FLAG-tag sequence at the N-terminus and Full-length Human receptor activity modifying protein 2 (RAMP2) cDNA (GenBank Accession Number NM_005854.2) with myc-tag at the C-terminus

Recommended Storage:
Liquid nitrogen upon receiving

Propagation Medium: DME/F12, 10% FBS, 10 µg/mL puromycin, 250µg/mL hygromycin

Stability:
Stable for a minimum of two months in continuous culture

Data Sheet

Background: Amylin receptors are multimeric complexes and have been closely associated with Calcitonin receptor (CT). CT, in the presence of the receptor activity modifying proteins (RAMP1, RAMP2 and RAMP3), forms pharmacologically distinct Amylin subtypes (AMY1, AMY2 and AMY3) which acts as a high affinity receptor for amylin, a hormone secrete by B cell of pancreas that has a major role in glucose regulation. The Calcitonin/RAMP2 complex has been known as the Amylin subtype AMY2 receptor.

Application: Functional assays

Figure 1. Dose-dependent increase of intracellular cAMP level upon treatment with ligand, measured with MultiscreenTM TR-FRET cAMP 1.0 No Wash Assay Kit (Multispan MSCM01). Figure 2. Receptor expression on cell surface measured by flow cytometry (FACS) using an anti-FLAG antibody. Thin line: parental cells; thick line: receptor-expressing cells.

References:

Morfis et al. (2008) Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-coupling Efficiency of Amylin Receptors. Endocrinology: 149(11):5423–5431.

Hay et al. (2005) Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes. Mol Pharmacol 67:1655–1665.

Gorn et al. (1992) Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest 90:1726-1735.

RJ Bailey et al.(2011). Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes. BJP 166:151–167

FOR RESEARCH USE ONLY.
All rights reserved. No part of this document may be reproduced in any form without prior permission in writing.

26219 Eden Landing Road Hayward, CA 94545 | (510) 887-0817 | info@multispaninc.com